Arnold Andrew
FARMINGTON, CONNECTICUT.
Trans Am Clin Climatol Assoc. 2016;127:235-244.
Primary hyperparathyroidism is primarily due to a solitary parathyroid adenoma but multi-gland disease, parathyroid carcinoma, and ectopic parathyroid hormone production can occur. Although primary hyperparathyroidism mostly presents sporadically, strong familial predispositions also exist. Much is known about heritable genetic mutations responsible for these syndromes, including multiple endocrine neoplasia types 1 and 2A, hyperparathyroidism-jaw tumor syndrome, and familial hypocalciuric hypercalcemia. Acquired mutations in common sporadic hyperparathyroidism have also been discovered. Here we focus on the most common and well-established genetic drivers: 1) involvement of the oncogene cyclin D1 in human neoplasia was first established in parathyroid adenomas, followed by recognition of its importance in other tumor types including breast cancer and B-lymphoid malignancy; and 2) somatic mutation of the gene, first identified as the source of pathogenic germline mutations in patients with familial endocrinopathies, is found in a substantial fraction of non-familial parathyroid adenomas.
原发性甲状旁腺功能亢进主要由单个甲状旁腺腺瘤引起,但也可能出现多腺体疾病、甲状旁腺癌和异位甲状旁腺激素分泌。虽然原发性甲状旁腺功能亢进大多为散发性,但也存在很强的家族易感性。对于导致这些综合征的遗传性基因突变,我们已经了解很多,包括多发性内分泌腺瘤1型和2A型、甲状旁腺功能亢进-颌骨肿瘤综合征以及家族性低钙血症性高钙血症。在常见的散发性甲状旁腺功能亢进中也发现了获得性突变。在此,我们重点关注最常见且已明确的遗传驱动因素:1)癌基因细胞周期蛋白D1在人类肿瘤中的作用最初是在甲状旁腺腺瘤中确定的,随后认识到其在包括乳腺癌和B淋巴细胞恶性肿瘤在内的其他肿瘤类型中的重要性;2)该基因的体细胞突变最初被确定为家族性内分泌病患者致病种系突变的来源,在相当一部分非家族性甲状旁腺腺瘤中也有发现。